What question did this study set out to answer?

The aim is to evaluate cell-based regenerative interventions in Parkinson's disease and their effectiveness in overcoming pharmacological limitations.

March 23, 2026Acta Pharmaceutica Sinica BOpen Access

Cell-based regenerative interventions in Parkinson’s disease: Overcoming pharmacological limitations

View Full Paper

Ask AI

Bookmark

Authors

APA. PadillaUniversidad de Valladolid JLJosé L. LanciegoBiomedical Research Networking Center on Neurodegenerative Diseases MVMiquel VilaInstitució Catalana de Recerca i Estudis Avançats

Discussion

Member takes

Implication

This review examines cell-based interventions for improving outcomes in Parkinson’s disease, highlighting therapeutic potential and challenges.

Key Points

The aim is to evaluate cell-based regenerative interventions in Parkinson's disease and their effectiveness in overcoming pharmacological limitations.
Reviewed various regenerative strategies including cell transplantation and reprogramming of endogenous cells.
Examined the role of supportive cell types like mesenchymal stromal cells.
Analyzed preclinical and clinical data on graft survival, integration, and functional recovery.
Identified promising evidence for restoring dopaminergic function through cell-based therapies.
Discussed significant challenges such as long-term graft integration and standardization.
Highlighted the importance of immune compatibility and bioenergetic integrity in enhancing therapeutic efficacy.

Cite This Study

Padilla et al. (2026) studied this question.

synapsesocial.com/papers/69c0df0bfddb9876e79c15de https://doi.org/10.1016/j.apsb.2026.03.031

View Full Paper

Ask AI

Bookmark

Implication

This review examines cell-based interventions for improving outcomes in Parkinson’s disease, highlighting therapeutic potential and challenges.